Sugarloaf Wealth Management, LLC Aprea Therapeutics, Inc. Transaction History

Sugarloaf Wealth Management, LLC

$493 Million
Q3 2024

Shares

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 03, 2023	BUY	$0.32 - $15.2 $3,200 - $152,000	10,000 Added 200.0%	15,000 $4,000
Q2 2022 Jul 12, 2022	BUY	$0.62 - $1.94 $2,170 - $6,790	3,500 Added 233.33%	5,000 $4,000
Q4 2020 Feb 03, 2021	BUY	$4.92 - $30.67 $7,380 - $46,005	1,500 New	1,500 $7,000

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,741
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sugarloaf Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sugarloaf Wealth Management, LLC with notifications on news.